{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:46:26Z","timestamp":1760647586722,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Takeda (Netherlands)","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>The early prediction of changes in disease state allows timely treatment of patients with inflammatory bowel disease (IBD) to be performed, which improves disease outcome. The aim of this pilot study is to explore the potential of fecal volatile organic compound (VOC) profiles to predict disease course. In this prospective cohort, IBD patients were asked to collect two fecal samples and fill in a questionnaire at set intervals. Biochemically, active disease was defined by FCP \u2265 250 mg\/g and remission was defined by FCP &lt; 100 mg\/g. Clinically, active disease was defined by a Harvey Bradshaw Index (HBI) \u2265 5 for Crohn\u2019s disease or by a Simple Clinical Colitis Activity Index (SCCAI) \u2265 3 for ulcerative colitis. Clinical remission was defined by an HBI &lt; 4 or SCCAI \u2264 2. Fecal VOC profiles were measured using gas chromatography-ion mobility spectrometry (GC-IMS). The fecal samples collected first were included for VOC analysis to predict disease state at the following collection. A total of 182 subsequently collected samples met the disease-state criteria. The fecal VOC profiles of samples displaying low FCP levels at the first measurements differed between patients preceding exacerbation versus those who remained in remission (AUC 0.75; p &lt; 0.01). Samples with FCP levels at the first time point displayed different VOC profiles in patients preceding remission compared with those whose disease remained active (AUC 0.86; p &lt; 0.01). Based on disease activity scores, there were no significant differences in any of the comparisons. Alterations in fecal VOC profiles preceding changes in FCP levels may be useful to detect disease-course alterations at an early stage. This could lead to earlier treatment, decreased numbers of complications, surgery and hospital admission.<\/jats:p>","DOI":"10.3390\/s22062316","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:37:17Z","timestamp":1647812237000},"page":"2316","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-1674","authenticated-orcid":false,"given":"Sofie","family":"Bosch","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dion S. J.","family":"Wintjens","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, MUMC+, Maastricht University, 6229 HX Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-1678","authenticated-orcid":false,"given":"Alfian","family":"Wicaksono","sequence":"additional","affiliation":[{"name":"School of Engineering, University of Warwick, Coventry CV4 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Pierik","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, MUMC+, Maastricht University, 6229 HX Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1307-6488","authenticated-orcid":false,"given":"James A.","family":"Covington","sequence":"additional","affiliation":[{"name":"School of Engineering, University of Warwick, Coventry CV4 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim G. J.","family":"de Meij","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, AG&M Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-9887","authenticated-orcid":false,"given":"Nanne K. H.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: Management of Crohn\u2019s Disease in Adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.giec.2019.02.003","article-title":"Prognosticating the Course of Inflammatory Bowel Disease","volume":"29","author":"Siegel","year":"2019","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): A multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2018","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ajg.2011.19","article-title":"The prognostic power of the NOD2 genotype for complicated Crohn\u2019s disease: A meta-analysis","volume":"106","author":"Adler","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_6","first-page":"978","article-title":"Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn\u2019s disease","volume":"20","author":"Rajca","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.chom.2018.09.009","article-title":"Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course","volume":"24","author":"Schirmer","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.cgh.2019.02.017","article-title":"Association Between Level of Fecal Calprotectin and Progression of Crohn\u2019s Disease","volume":"17","author":"Kennedy","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"027106","DOI":"10.1088\/1752-7155\/8\/2\/027106","article-title":"Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry","volume":"8","author":"Boots","year":"2014","journal-title":"J. Breath Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1096\/fj.06-6927com","article-title":"Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease","volume":"21","author":"Garner","year":"2007","journal-title":"FASEB J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MPG.0000000000001250","article-title":"Sniffing out paediatric gastrointestinal diseases: The potential of volatile organic compounds as biomarkers for disease","volume":"63","author":"Buijck","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/apt.13522","article-title":"Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease","volume":"43","author":"Ahmed","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/ibd\/izy151","article-title":"Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study","volume":"24","author":"Bosch","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dld.2020.03.007","article-title":"The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis","volume":"52","author":"Bosch","year":"2020","journal-title":"Dig. Liver Dis."},{"doi-asserted-by":"crossref","unstructured":"El Manouni El Hassani, S., Bosch, S., Lemmen, J.P.M., Brizzio Brentar, M., Ayada, I., Wicaksono, A.N., Covington, J.A., Benninga, M.A., de Boer, N.K.H., and de Meij, T.G.J. (2019). Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD. Sensors, 19.","key":"ref_15","DOI":"10.3390\/s19204496"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/MIB.0000000000000436","article-title":"Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn\u2019s Disease: A Metabolomic Approach","volume":"21","author":"Bodelier","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"Ferrante","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/j.crohns.2013.05.005","article-title":"A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn\u2019s disease","volume":"7","author":"Lobaton","year":"2013","journal-title":"J. Crohn Colitis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","article-title":"Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease","volume":"119","author":"Tibble","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1136\/gutjnl-2012-303957","article-title":"Role of endoscopy, cross-sectional imaging and biomarkers in Crohn\u2019s disease monitoring","volume":"62","author":"Benitez","year":"2013","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/gut.35.2.231","article-title":"Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn\u2019s disease. A prospective multicentre study of 121 cases. The Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives","volume":"35","author":"Cellier","year":"1994","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/CCLM.2005.073","article-title":"How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?","volume":"43","author":"Jorgensen","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"doi-asserted-by":"crossref","unstructured":"Arasaradnam, R.P., McFarlane, M.J., Ryan-Fisher, C., Westenbrink, E., Hodges, P., Thomas, M.G., Chambers, S., O\u2019Connell, N., Bailey, C., and Harmston, C. (2014). Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PLoS ONE, 9.","key":"ref_23","DOI":"10.1371\/journal.pone.0108750"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ilar\/ilv030","article-title":"The Intestinal Microbiota in Inflammatory Bowel Disease","volume":"56","author":"Becker","year":"2015","journal-title":"ILAR J."},{"doi-asserted-by":"crossref","unstructured":"Martinez, I., Muller, C.E., and Walter, J. (2013). Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species. PLoS ONE, 8.","key":"ref_25","DOI":"10.1371\/journal.pone.0069621"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1237439","DOI":"10.1126\/science.1237439","article-title":"The long-term stability of the human gut microbiota","volume":"341","author":"Faith","year":"2013","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1572-0241.2007.01592.x","article-title":"Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission","volume":"103","author":"Martinez","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","article-title":"Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach","volume":"55","author":"Manichanh","year":"2006","journal-title":"Gut"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"doi-asserted-by":"crossref","unstructured":"Walker, A.W., Sanderson, J.D., Churcher, C., Parkes, G.C., Hudspith, B.N., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G., and Petrovska, L. (2011). High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol., 11.","key":"ref_32","DOI":"10.1186\/1471-2180-11-7"},{"doi-asserted-by":"crossref","unstructured":"Wills, E.S., Jonkers, D.M., Savelkoul, P.H., Masclee, A.A., Pierik, M.J., and Penders, J. (2014). Fecal microbial composition of ulcerative colitis and Crohn\u2019s disease patients in remission and subsequent exacerbation. PLoS ONE, 9.","key":"ref_33","DOI":"10.1371\/journal.pone.0090981"}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/22\/6\/2316\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:38:00Z","timestamp":1760135880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/22\/6\/2316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["s22062316"],"URL":"https:\/\/doi.org\/10.3390\/s22062316","relation":{},"ISSN":["1424-8220"],"issn-type":[{"type":"electronic","value":"1424-8220"}],"subject":[],"published":{"date-parts":[[2022,3,17]]}}}